FDA Inspection 971651 — Daiichi Sankyo Co., Ltd. Hiratsuka Plant
The FDA completed an inspection of Daiichi Sankyo Co., Ltd. Hiratsuka Plant on April 22, 2016 in Hiratsuka. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- April 22, 2016
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Hiratsuka (Japan)